INSR and Alzheimer disease: For example, reduced insulin, insulin receptor, IGF1 and IGF2, reduced total IRS1 mRNA expression, and reduced protein indicators of downstream insulin signaling activity (including p85‐associated IRS1, phosphorylated AKT) have been reported in postmortem AD brain (Steen et al., 2005).